Notice2025-03221
Notice Pursuant to the National Cooperative Research and Production Act of 1993-Rapid Response Partnership Vehicle
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 28, 2025
Issuing agencies
Justice DepartmentAntitrust Division
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 39 (Friday, February 28, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 39 (Friday, February 28, 2025)]
[Notices]
[Pages 10949-10950]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-03221]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Rapid Response Partnership Vehicle
Notice is hereby given that, on January 16, 2025, pursuant to
section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Rapid Response Partnership
Vehicle (``RRPV'') has filed written notifications simultaneously with
the Attorney General and the Federal Trade Commission disclosing
changes in its membership. The notifications were filed for the purpose
of extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, Fisher BioServices, Inc., Rockville, MD; Landmark
Vaccines, Ltd., Loughborough, UNITED KINGDOM; Rx Bandz, Locust Valley,
NY; Zeteo Tech, Inc., Sykesville, MD; BioNet-Asia Co., Ltd, Bangkok,
KINGDOM OF THAILAND; EmitBio, Inc., Morrisville, NC; Matisse
Pharmaceuticals, B.V., Geleen, KINGDOM OF THE NETHERLANDS; National
Institute for Pharmaceutical Technology and Education, Inc.,
Minneapolis, MN; ProtonDx, Ltd., London, UNITED KINGDOM; BioVaxys
Technology Corp., North Miami, FL; Enplas, Santa Clara, CA; RHEAVITA
BV, Ghent, BELGIUM; Celltheon, Union City, CA; Chromatan, Inc., Lower
Gwynedd, PA; Cyrus Biotechnology, Seattle, WA; Eradivir, Inc., West
Lafayette, IN; InDevR, Inc., Boulder, CO; Kudo Biotechnology, Inc.,
Needham, MA; Panoplia Laboratories, Inc., Cambridge, MA; The Regents of
the University of California on behalf of its Los Angeles campus, Los
Angeles, CA; Meridian Medical Technologies LLC, St. Louis, MO; Sarfez
Pharmaceuticals, Inc., Vienna, VA; Tiba Biotech LLC, Cambridge, MA;
Ecolab, Inc., Philadelphia, PA; Unicorn Biotechnologies, Inc., Newark,
NJ; Zipcode Bio, Weston, MA; Acclinate, Inc., Birmingham, AL; Klim-Loc
Medical, Inc., Carbondale, CO; Primary Diagnostics, Inc. dba
Primary.Health, San Francisco, CA; Epitogenesis, Inc., Virginia Beach,
VA; Microbio, Ltd., Brisbane, AUSTRALIA; Aldevron LLC, Fargo, ND; BC3
Technologies, Inc., Baltimore, MD; Genvax, Ames, IA; Maxim Biomedical,
Inc., Rockville, MD; Piezo Therapeutics, Inc., Atlanta, GA; Virtu,
Inc., Leesburg, VA; Digital Infuzion LLC, Rockville, MD; Neolixir,
Ltd., Perth, AUSTRALIA; and XCMR, Inc., Narberth, PA have been added as
parties to this venture.
Also, TFF Pharmaceuticals, Inc., Fort Worth, TX has withdrawn as a
party to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and RRPV intends to file additional
written notifications disclosing all changes in membership.
On January 5, 2024, RRPV filed its original notification pursuant
to section 6(a) of the Act. The Department of Justice published a
notice in the Federal Register pursuant to section 6(b) of the Act on
April 16, 2024 (89 FR 26928).
The last notification was filed with the Department on October 3,
2024. The Department of Justice published a notice in the Federal
Register pursuant to
[[Page 10950]]
section 6(b) of the Act on December 20, 2024 (89 FR 104208).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2025-03221 Filed 2-27-25; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on February 28, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.